| 发明名称 |
CRYSTALLINE FORMS OF ATORVASTATIN |
| 摘要 |
The present invention is directed to new crystalline forms of Atorvastatin calcium (2:1), referred to hereinafter as polymorphic Forms X, A, B, B2, C, D and E. Furthermore, the present invention is directed to processes for the preparation of these crystalline forms and pharmaceutical compositions comprising the crystalline forms. |
| 申请公布号 |
CA2623600(A1) |
申请公布日期 |
2002.07.04 |
| 申请号 |
CA20012623600 |
申请日期 |
2001.12.19 |
| 申请人 |
TEVA PHARMACEUTICALS INDUSTRIES LTD. |
发明人 |
SCHOENING, KAI-UWE;BLATTER, FRITZ;VAN DER SCHAAF, PAUL ADRIAN;SZELAGIEWICZ, MARTIN |
| 分类号 |
C07D207/34;A61K31/40;A61P3/06;A61P43/00 |
主分类号 |
C07D207/34 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
